Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
Research and development $ 5,331 $ 2,664 $ 9,951 $ 5,425
General and administrative 2,861 1,138 6,136 2,367
Total operating expenses 8,192 3,802 16,087 7,792
Loss from operations (8,192) (3,802) (16,087) (7,792)
Other income:        
Interest income 40 444 450 902
Net loss (8,152) (3,358) (15,637) (6,890)
Deemed dividend       (5,326)
Net loss attributable to common stockholders (8,152) (3,358) (15,637) (12,216)
Other comprehensive income:        
Net unrealized gain on available-for-sale investments, net of tax 11   11  
Net comprehensive loss $ (8,141) $ (3,358) $ (15,626) $ (12,216)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.35) $ (1.87) $ (0.68) $ (7.48)